![Amy Chevalier Efantis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy Chevalier Efantis served as the President & Chief Executive Officer of Plasma Protein Therapeutics Association from 2019 to 2023.
She also worked as the Vice President-Government Affairs at Biogen, Inc.
| Sociétés | Poste | Fin |
|---|---|---|
Plasma Protein Therapeutics Association
 Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services Non-profit organization representing manufacturers and plasma collection centers | Directeur Général | 17/04/2023 |
| BIOGEN INC. | Conseiller Juridique Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services Non-profit organization representing manufacturers and plasma collection centers | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
